Pedifen tablets

Form: Tablets
Dosage: 400mg
Packaging: 30 film-coated tablets

Active substance: ibuprofen

Form: film-coated tablet

Dosage: Each Pedifen tablet contains 400 mg of ibuprofen

 

Packaging: Box of 30 tablets

 

Target: Adults and children from 12 years

For children aged 6 months to 12 years, there is an oral suspension of Pedifen which is more appropriate for correct dosages in relation to body weight.

Symptomatic treatment in case of:

– mild to moderate pain and fever

– primary dysmenorrhoea

– mild to moderate inflammation (especially of the locomotive system)

Adults and children from 12 years of age:

Initial dose 400mg to max 800, followed, if necessary, by 400mg to 800mg 2 to 4 times daily.

Dosage may be adjusted according to severity and individual reaction of the patient.

The lowest effective dose should be used for the shortest time necessary to relieve symptoms.

In sensitive stomach patients, it is advisable to take PEDIFEN® with a meal.

Over-the-counter drug

Notice of Trademark Infringement

Dear valued partners, customers and Dafra representatives,

It has come to our attention that unauthorized use of our company’s name and logo has been observed in various contexts in the African country Togo (https://www.dafrapharma-vet.com/). In order to avoid misunderstandings, ever misleading, we feel it is imperative to address this issue promptly and transparently.

Trademark infringement poses a significant threat not only to our brand integrity but also to the trust and credibility we have worked diligently to establish within our community. Our name and logo represent our values, quality, and commitment to excellence, and any unauthorized use undermines these principles.

We take trademark infringement seriously and are actively taking measures to address any instances of unauthorized use. This includes legal action against parties found to be infringing upon our intellectual property rights.

We urge our customers, partners, African representatives and the general public to remain vigilant and report any suspected instances of trademark infringement directly to us. Your cooperation in this matter is crucial in helping us protect our brand and preserve the integrity of our business.

As always, we remain dedicated to providing high quality medical solutions in the sub-Sahara region of Africa and maintaining the highest standards of integrity and professionalism.

Thank you for your continued support and trust in our company.

Dafra Pharma